![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom
It is now generally accepted that G protein-coupled receptors (GPCRs) can exist as dimers or as part of larger oligomeric complexes. Increasing evidence suggests that a dimer is the minimal functional structure, but considerable variation exists between reports of the effects of agonist ligands on quaternary structure. Many studies have intimated the existence of heterodimeric GPCR pairings. Key questions that remain to be addressed effectively include the prevalence and relevance of these in native tissues and the implications of heterodimerization for pharmacology and, potentially, for drug design.
Address correspondence to: Graeme Milligan, Molecular Pharmacology Group, Davidson Building, University of Glasgow, Glasgow G12 8QQ Scotland, UK. E-mail: g.milligan{at}bio.gla.ac.uk
This article has been cited by other articles:
|
|
 |
|
  M.-J. Rabiet, E. Huet, and F. Boulay Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation J. Biol. Chem., November 7, 2008; 283(45): 31038 - 31046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Korstanje, J. Desai, G. Lazar, B. King, J. Rollins, M. Spurr, J. Joseph, S. Kadambi, Y. Li, A. Cherry, et al. Quantitative trait loci affecting phenotypic variation in the vacuolated lens mouse mutant, a multigenic mouse model of neural tube defects Physiol Genomics, November 1, 2008; 35(3): 296 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Borlak and H. S. Jenke Cross-talk between Aryl Hydrocarbon Receptor and Mitogen-Activated Protein Kinase Signaling Pathway in Liver Cancer through c-raf Transcriptional Regulation Mol. Cancer Res., August 1, 2008; 6(8): 1326 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Patel and R. S. Ostrom An orphan GPCR finds a home in the heart Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H479 - H481. [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Evans and J. W. Walker Endothelin Receptor Dimers Evaluated by FRET, Ligand Binding, and Calcium Mobilization Biophys. J., July 1, 2008; 95(1): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood, July 1, 2008; 112(1): 34 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Harrison, L. Lyon, L. Sartorius, P. Burnet, and T. Lane Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia J Psychopharmacol, May 1, 2008; 22(3): 308 - 322. [Abstract] [PDF]
|
|
|
|
 |
|
 A. K. Shukla, J.-P. Sun, and R. J. Lefkowitz Crystallizing Thinking about the {beta}2-Adrenergic Receptor Mol. Pharmacol., May 1, 2008; 73(5): 1333 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Muller, N. Wu, and K. Palczewski Vertebrate Membrane Proteins: Structure, Function, and Insights from Biophysical Approaches Pharmacol. Rev., March 1, 2008; 60(1): 43 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nomura, Y. Suzuki, A. Kakizuka, and H. Jingami Direct Detection of the Interaction between Recombinant Soluble Extracellular Regions in the Heterodimeric Metabotropic {gamma}-Aminobutyric Acid Receptor J. Biol. Chem., February 22, 2008; 283(8): 4665 - 4673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Cherezov, D. M. Rosenbaum, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. S. Kobilka, H.-J. Choi, P. Kuhn, W. I. Weis, B. K. Kobilka, et al. High-Resolution Crystal Structure of an Engineered Human 2-Adrenergic G Protein Coupled Receptor Science, November 23, 2007; 318(5854): 1258 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brock, N. Oueslati, S. Soler, L. Boudier, P. Rondard, and J.-P. Pin Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement J. Biol. Chem., November 9, 2007; 282(45): 33000 - 33008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Harikumar, D. I. Pinon, and L. J. Miller Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor J. Biol. Chem., October 19, 2007; 282(42): 30363 - 30372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Mikhailova, P. R. Mayeux, A. Jurkevich, W. J. Kuenzel, F. Madison, A. Periasamy, Y. Chen, and L. E. Cornett Heterooligomerization between Vasotocin and Corticotropin-Releasing Hormone (CRH) Receptors Augments CRH-Stimulated 3',5'-Cyclic Adenosine Monophosphate Production Mol. Endocrinol., September 1, 2007; 21(9): 2178 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Lunzer and P. S. Portoghese Selectivity of {delta}- and {kappa}-Opioid Ligands Depends on the Route of Central Administration in Mice J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 166 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. P. Ernst, V. Gramse, M. Kolbe, K. P. Hofmann, and M. Heck Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit PNAS, June 26, 2007; 104(26): 10859 - 10864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Lopez-Gimenez, M. Canals, J. D. Pediani, and G. Milligan The {alpha}1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and Function Mol. Pharmacol., April 1, 2007; 71(4): 1015 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, J. A. Javitch, M. J. Lohse, G. Milligan, K. Palczewski, M. Parmentier, et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers Pharmacol. Rev., March 1, 2007; 59(1): 5 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Baker and S. J. Hill A Comparison of the Antagonist Affinities for the Gi- and Gs-Coupled States of the Human Adenosine A1-Receptor J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 218 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ellis, J. D. Pediani, M. Canals, S. Milasta, and G. Milligan Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and Function J. Biol. Chem., December 15, 2006; 281(50): 38812 - 38824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Albizu, M.-N. Balestre, C. Breton, J.-P. Pin, M. Manning, B. Mouillac, C. Barberis, and T. Durroux Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding Mol. Pharmacol., November 1, 2006; 70(5): 1783 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fry, P. M. Smith, T. D. Hoyda, M. Duncan, R. S. Ahima, K. A. Sharkey, and A. V. Ferguson Area postrema neurons are modulated by the adipocyte hormone adiponectin. J. Neurosci., September 20, 2006; 26(38): 9695 - 9702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Kim, D. Zitnan, K.-H. Cho, D. A. Schooley, A. Mizoguchi, and M. E. Adams Central peptidergic ensembles associated with organization of an innate behavior PNAS, September 19, 2006; 103(38): 14211 - 14216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, W. K. Vogel, J. S. McCullar, J. A. Greenwood, and T. M. Filtz Phospholipase C-beta3 and -beta1 Form Homodimers, but Not Heterodimers, through Catalytic and Carboxyl-Terminal Domains Mol. Pharmacol., September 1, 2006; 70(3): 860 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rouzaud, G.-E. Costin, Y. Yamaguchi, J. C. Valencia, W. F. Berens, K. G. Chen, T. Hoashi, M. Bohm, Z. A. Abdel-Malek, and V. J. Hearing Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms FASEB J, September 1, 2006; 20(11): 1927 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jiang, L. Betancourt, and R. G. Smith Ghrelin Amplifies Dopamine Signaling by Cross Talk Involving Formation of Growth Hormone Secretagogue Receptor/Dopamine Receptor Subtype 1 Heterodimers Mol. Endocrinol., August 1, 2006; 20(8): 1772 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Snook, G. Milligan, B. L. Kieffer, and D. Massotte {micro}-{delta} Opioid Receptor Functional Interaction: Insight Using Receptor-G Protein Fusions J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 683 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Lodowski, V. M. Tesmer, J. L. Benovic, and J. J. G. Tesmer The Structure of G Protein-coupled Receptor Kinase (GRK)-6 Defines a Second Lineage of GRKs J. Biol. Chem., June 16, 2006; 281(24): 16785 - 16793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Giembycz and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Raiteri Functional pharmacology in human brain. Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Toews Adenosine Receptors Find a New Partner and Move Out Mol. Pharmacol., April 1, 2006; 69(4): 1075 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Hildebrandt Bring Your Own G Protein Mol. Pharmacol., April 1, 2006; 69(4): 1079 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Meyer, J.-M. Segura, K. L. Martinez, R. Hovius, N. George, K. Johnsson, and H. Vogel FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells PNAS, February 14, 2006; 103(7): 2138 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Milasta, J. Pediani, S. Appelbe, S. Trim, M. Wyatt, P. Cox, M. Fidock, and G. Milligan Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD Mol. Pharmacol., February 1, 2006; 69(2): 479 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Harikumar, M. M. Morfis, C. S. Lisenbee, P. M. Sexton, and L. J. Miller Constitutive Formation of Oligomeric Complexes between Family B G Protein-Coupled Vasoactive Intestinal Polypeptide and Secretin Receptors Mol. Pharmacol., January 1, 2006; 69(1): 363 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nobles, A. Benians, and A. Tinker Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells PNAS, December 20, 2005; 102(51): 18706 - 18711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Guo, L. Shi, M. Filizola, H. Weinstein, and J. A. Javitch From The Cover: Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface determine activation PNAS, November 29, 2005; 102(48): 17495 - 17500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fan, G. Varghese, T. Nguyen, R. Tse, B. F. O'Dowd, and S. R. George A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of {micro} and {delta} Opioid Receptor Hetero-oligomers J. Biol. Chem., November 18, 2005; 280(46): 38478 - 38488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. O'Dowd, X. Ji, M. Alijaniaram, R. D. Rajaram, M. M. C. Kong, A. Rashid, T. Nguyen, and S. R. George Dopamine Receptor Oligomerization Visualized in Living Cells J. Biol. Chem., November 4, 2005; 280(44): 37225 - 37235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Calebiro, T. de Filippis, S. Lucchi, C. Covino, S. Panigone, P. Beck-Peccoz, D. Dunlap, and L. Persani Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance Hum. Mol. Genet., October 15, 2005; 14(20): 2991 - 3002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Emanuel, C. A. Rugg, R. H. Gruninger, R. Lin, A. Fuentes-Pesquera, P. J. Connolly, S. K. Wetter, B. Hollister, W. W. Kruger, C. Napier, et al. The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases Cancer Res., October 1, 2005; 65(19): 9038 - 9046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alba and R. Salvatori Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding J. Endocrinol., September 1, 2005; 186(3): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Prinster, C. Hague, and R. A. Hall Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pascal and G. Milligan Functional Complementation and the Analysis of Opioid Receptor Homodimerization Mol. Pharmacol., September 1, 2005; 68(3): 905 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wilson, G. Wilkinson, and G. Milligan The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities J. Biol. Chem., August 5, 2005; 280(31): 28663 - 28674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Rangon, S. Goursaud, F. Medja, V. Lelievre, L. Mounien, I. Husson, P. Brabet, S. Jegou, T. Janet, and P. Gressens VPAC2 Receptors Mediate Vasoactive Intestinal Peptide-Induced Neuroprotection against Neonatal Excitotoxic Brain Lesions in Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Changeux and S. J. Edelstein Allosteric Mechanisms of Signal Transduction Science, June 3, 2005; 308(5727): 1424 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Barwell, J. H. Boysen, W. Xu, and A. P. Mitchell Relationship of DFG16 to the Rim101p pH Response Pathway in Saccharomyces cerevisiae and Candida albicans Eukaryot. Cell, May 1, 2005; 4(5): 890 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Thomas Double Trouble for Type 1 Angiotensin Receptors in Atherosclerosis N. Engl. J. Med., February 3, 2005; 352(5): 506 - 508. [Full Text] [PDF]
|
|
|
|
|
|
L. Kantor, M. Zhang, B. Guptaroy, Y. H. Park, and M. E. Gnegy Repeated Amphetamine Couples Norepinephrine Transporter and Calcium Channel Activities in PC12 Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1044 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Carrillo, J. F. Lopez-Gimenez, and G. Milligan Multiple Interactions between Transmembrane Helices Generate the Oligomeric {alpha}1b-Adrenoceptor Mol. Pharmacol., November 1, 2004; 66(5): 1123 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Gironacci, M. S. Valera, I. Yujnovsky, and C. Pena Angiotensin-(1-7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats Hypertension, November 1, 2004; 44(5): 783 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pollack Coactivation of D1 and D2 Dopamine Receptors: In Marriage, a Case of His, Hers, and Theirs Sci. Signal., October 19, 2004; 2004(255): pe50 - pe50. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
